4//SEC Filing
ORBIMED ADVISORS LLC 4
Accession 0001235802-21-000109
CIK 0001453593other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 5:58 PM ET
Size
10.3 KB
Accession
0001235802-21-000109
Insider Transaction Report
Form 4
Orbimed ROF II LLC
Director10% Owner
Transactions
- Other
Common Stock
2021-08-15+85,337→ 120,549 total(indirect: See Footnotes) - Other
Common Stock
2021-08-15+85,337→ 120,549 total(indirect: See Footnotes)
ORBIMED ADVISORS LLC
10% Owner
Transactions
- Other
Common Stock
2021-08-15+85,337→ 120,549 total(indirect: See Footnotes) - Other
Common Stock
2021-08-15+85,337→ 120,549 total(indirect: See Footnotes)
Footnotes (4)
- [F1]See Exhibit 99.1.
- [F2]These shares are subject to restricted stock unit awards granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended, and vest and become issuable on August 15, 2022, conditioned upon the reporting person remaining a director of Xtant through the vesting date.
- [F3]This report on Form 4 is jointly filed by Advisors and ROF II. Each of ROS Acquisition and ORO II disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. Advisors has designated certain representatives, including Matthew Rizzo and Michael Eggenberg, both of whom are employees of Advisors, to serve on Xtant's board of directors. This report shall not be deemed an admission that any such entity is a beneficial owner of such securities for the purposes of Section 16 of the Exchange Act or for any other purposes.
- [F4]See Exhibit 99.2.
Documents
Issuer
Xtant Medical Holdings, Inc.
CIK 0001453593
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001055951
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 5:58 PM ET
- Size
- 10.3 KB